Neumora Therapeutics, Inc.

Contributing Author

Recent Articles by Neumora Therapeutics, Inc.

Aug-06	Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update NMRA GlobeNewswire
Jul-23	Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 NMRA GlobeNewswire
Jul-09	Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861 NMRA GlobeNewswire
May-12	Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update NMRA GlobeNewswire